Pitfalls, Perils and Pearls: Identifying and Managing Gynecologic Treatment Toxicity
The introduction of novel therapies for gynecologic malignancies such as immunotherapy, SBRT and complex brachytherapy can lead to increased frequency of severe toxicities for which treatment options may be limited.
Category
  • Immunotherapy
  • SBRT
  • Gynecologic Cancer
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $0.00
Evolving Therapeutic Strategies in the Multidisciplinary Management of Patients with Hepatocellular Carcinoma – Improving Outcomes
The management of Hepatocellular Carcinoma (HCC) should be conducted in a multidisciplinary setting to offer individualized therapy. Most patients with HCC are not candidates for curative treatments because of tumor extent or underlying liver dysfunction.
Category
  • SBRT
  • Other
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $0.00

Pages